ObjectiveThis review investigates the prevalence of male non‐neurogenic lower urinary tract symptoms (LUTS) after renal transplant, as kidney transplantation is a transformative intervention for patients with end‐stage renal disease significantly enhancing quality of life that might be diminished by LUTS.MethodsThe Preferred Reporting Items for Systematic Reviews and Meta‐Analyses guidelines were followed. A systematic search in the PubMed and Scopus databases was performed using specific terms. Inclusion criteria considered male kidney transplant recipients, analysing outcomes in English‐language studies. Discrepancies were resolved by consultation.ResultsAmong 18 studies involving 29 086 recipients, the prevalence of non‐neurogenic LUTS ranged from 5.8% to 33.0%. Studies predominantly used the International Prostate Symptom Score for evaluation. Surgical interventions, mostly for benign prostatic obstruction, ranged from 2.5% to 20.0%. Voiding and post‐micturition symptoms were under‐represented.ConclusionThis review found varied non‐neurogenic LUTS prevalence and characteristics in male kidney transplant recipients, emphasising the need for standardised assessments, prospective studies, and improved understanding of LUTS mechanisms. Enhanced knowledge can guide interventions, additionally benefiting recipient quality of life.

中文翻译：

---

肾移植后非神经源性男性下尿路症状的患病率

目的本综述调查了肾移植后男性非神经源性下尿路症状 (LUTS) 的患病率，因为肾移植是终末期肾病患者的一种变革性干预措施，可显着提高可能因 LUTS 而降低的生活质量。遵循系统评价和荟萃分析指南的报告项目。使用特定术语在 PubMed 和 Scopus 数据库中进行系统检索。纳入标准考虑了男性肾移植受者，分析了英语研究的结果。差异通过咨询解决。结果在涉及29 086名受者的18项研究中，非神经源性LUTS的患病率范围为5.8%至33.0%。研究主要使用国际前列腺症状评分进行评估。手术干预主要针对良性前列腺梗阻，占 2.5% 至 20.0%。排尿和排尿后症状代表性不足。结论本综述发现男性肾移植受者中非神经源性 LUTS 的患病率和特征各不相同，强调需要标准化评估、前瞻性研究和提高对 LUTS 机制的理解。增强的知识可以指导干预措施，另外有利于接受者的生活质量。